302 related articles for article (PubMed ID: 37762936)
1. Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations.
Watanabe R; Hashimoto M
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762936
[TBL] [Abstract][Full Text] [Related]
2. Update on eosinophilic granulomatosis with polyangiitis.
Furuta S; Iwamoto T; Nakajima H
Allergol Int; 2019 Oct; 68(4):430-436. PubMed ID: 31266709
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic granulomatosis with polyangitis: A new target for biologicals.
Bayrak Durmaz MS; Çelebi Sözener Z; Bavbek S
Tuberk Toraks; 2022 Mar; 70(1):93-101. PubMed ID: 35362309
[TBL] [Abstract][Full Text] [Related]
4. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].
Hellmich B; Holle J; Moosig F
Z Rheumatol; 2022 May; 81(4):286-299. PubMed ID: 35075511
[TBL] [Abstract][Full Text] [Related]
5. A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.
Koike H; Nishi R; Yagi S; Furukawa S; Fukami Y; Iijima M; Katsuno M
Adv Ther; 2023 Jan; 40(1):25-40. PubMed ID: 36152266
[TBL] [Abstract][Full Text] [Related]
6. Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan.
Yamane T; Hashiramoto A
Arthritis Res Ther; 2023 Jun; 25(1):110. PubMed ID: 37365612
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology.
Fagni F; Bello F; Emmi G
Front Med (Lausanne); 2021; 8():627776. PubMed ID: 33718405
[TBL] [Abstract][Full Text] [Related]
8. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
Ennis D; Lee JK; Pagnoux C
Expert Opin Biol Ther; 2019 Jul; 19(7):617-630. PubMed ID: 31146595
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
[TBL] [Abstract][Full Text] [Related]
10. Role of Cytokines in EGPA and the Possibility of Treatment with an Anti-IL-5 Antibody.
Isozaki T; Homma T; Sagara H; Kasama T
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33265990
[TBL] [Abstract][Full Text] [Related]
11. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
[TBL] [Abstract][Full Text] [Related]
12. A case of subarachnoid haemorrhage associated with MPO-ANCA-positive eosinophilic granulomatosis with polyangiitis, successfully treated with glucocorticoid, cyclophosphamide, and mepolizumab.
Satake Y; Sakai S; Takao T; Saeki T
Mod Rheumatol Case Rep; 2023 Dec; ():. PubMed ID: 38109745
[TBL] [Abstract][Full Text] [Related]
13. ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics.
Piga MA; Fraticelli P; Antonicelli L; Garritani MS; Ghirelli G; Martini M; Di Vincenzo A; Danieli MG; Moroncini G; Bilò MB
Front Immunol; 2023; 14():1325299. PubMed ID: 38090592
[TBL] [Abstract][Full Text] [Related]
14. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
McBrien CN; Menzies-Gow A
Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil Cytoplasmic Antibodies and Organ-Specific Manifestations in Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis.
Chang HC; Chou PC; Lai CY; Tsai HH
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):445-452.e6. PubMed ID: 32771687
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort.
Liu S; Han L; Liu Y; Yang J; Zhang Y; Li M; Tian X; Zeng X; Wang L; Zhang F
Front Immunol; 2022; 13():885198. PubMed ID: 35833130
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilic granulomatosis with polyangiitis.
Villa-Forte A
Postgrad Med; 2023 Jan; 135(sup1):52-60. PubMed ID: 36259957
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment With Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A Case Report.
Toscano Peña A; Ali Munive A; Arevalo Y
Cureus; 2023 May; 15(5):e38797. PubMed ID: 37303316
[TBL] [Abstract][Full Text] [Related]
19. Recurrent atelectasis and brain infarction in a patient with anti-neutrophil antibody negative eosinophilic granulomatosis with polyangiitis: a case report.
Sada KE; Miyauchi A; Hashimoto D; Ino R; Nojima S; Yamanaka S; Kawamura M
BMC Rheumatol; 2021 Sep; 5(1):28. PubMed ID: 34465397
[TBL] [Abstract][Full Text] [Related]
20. A Rare Geriatric Diagnosis of Eosinophilic Granulomatosis With Polyangiitis: A Case Report.
Emidio FC; Pereira RC; Martins FR; Marques RC; Martins T
Cureus; 2023 Feb; 15(2):e35398. PubMed ID: 36846640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
